New insider activity at Callan JMB, Inc. ( (CJMB) ) has taken place on April 4, 2025.
CMO David J Croyle has made a significant investment in Callan JMB, Inc. by purchasing 25,000 shares of the company’s stock. This transaction is valued at $112,500, showcasing his confidence in the company’s future prospects.
Recent Updates on CJMB stock
In recent developments, Callan JMB, Inc. experienced a 3% increase in its stock price in pre-market trading, reaching $4.45. This movement follows significant insider buying, with CEO Wayne Williams purchasing 63,000 shares and Chief Medical Officer David Croyle acquiring 24,400 shares. Additionally, the company has been active in expanding its business operations, unveiling an immunization management lease program and completing an immunization program with Health Hero Tennessee. Furthermore, Callan JMB received a request from the State of Texas DHHS to be on standby and was awarded a second five-year contract by the Oregon Health Authority. These strategic moves and insider confidence likely contributed to the positive market response.
More about Callan JMB, Inc.
YTD Price Performance: 3.66%
Average Trading Volume: 306,817